1 |
Atsukawa M, Tsubota A, Hatano M, Kondo C, Shioda K, Ohno H, Kawano T, Hayama K, Arai T, Nakagawa-Iwashita A, Itokawa N, Kaneko K, Yoshida Y, Koeda M, Okubo T, Yamamoto T, Yamamoto T, Taniai N, Yoshida H, Kanazawa H, Shimizu W, Iwakiri K. Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization. Hepatol Res 2020;50:1244-54. [PMID: 32822521 DOI: 10.1111/hepr.13560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
2 |
Ueno W, Sato N, Miura K, Morimoto N, Watanabe S, Nomoto H, Isoda N, Kijima S, Kikuchi T, Manaka S, Mori H, Yamamoto H. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis. Clin J Gastroenterol 2021;14:1227-32. [PMID: 33993428 DOI: 10.1007/s12328-021-01441-3] [Reference Citation Analysis]
|
3 |
Takakusagi S, Shimizu M, Yokoyama Y, Kizawa K, Marubashi K, Kosone T, Sato K, Kakizaki S, Takagi H, Uraoka T. Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir. Clin J Gastroenterol 2020;13:1303-9. [PMID: 32914297 DOI: 10.1007/s12328-020-01229-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|